19 articles for C Tallant
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
3
Development of Selective CBP/P300 Benzoxazepine Bromodomain Inhibitors.

Ludwig-Maximilians-Universit£T M£Nchen
8
Discovery and Optimization of a Selective Ligand for the Switch/Sucrose Nonfermenting-Related Bromodomains of Polybromo Protein-1 by the Use of Virtual Screening and Hydration Analysis.

University of Athens
12
Identification and Development of 2,3-Dihydropyrrolo[1,2-a]quinazolin-5(1H)-one Inhibitors Targeting Bromodomains within the Switch/Sucrose Nonfermenting Complex.

University of Cambridge
23
Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor.

Boehringer Ingelheim Rcv
3
Identification of a Chemical Probe for Family VIII Bromodomains through Optimization of a Fragment Hit.

Pfizer
5
New Synthetic Routes to Triazolo-benzodiazepine Analogues: Expanding the Scope of the Bump-and-Hole Approach for Selective Bromo and Extra-Terminal (BET) Bromodomain Inhibition.

University of Dundee
25
Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF.

University of Oxford
22
Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B.

Glaxosmithkline
1
LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor.

University of Oxford
1
Promiscuous targeting of bromodomains by bromosporine identifies BET proteins as master regulators of primary transcription response in leukemia.

University of Oxford
1
Structure enabled design of BAZ2-ICR, a chemical probe targeting the bromodomains of BAZ2A and BAZ2B.

Cancer Research Uk Cancer Therapeutics Unit
1
CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses.

University of Oxford
1
Selective targeting of the BRG/PB1 bromodomains impairs embryonic and trophoblast stem cell maintenance.

University of Oxford
8
Exploiting a water network to achieve enthalpy-driven, bromodomain-selective BET inhibitors.

St. Jude Children'S Research Hospital
16
Design of a Biased Potent Small Molecule Inhibitor of the Bromodomain and PHD Finger-Containing (BRPF) Proteins Suitable for Cellular and in Vivo Studies.

University College London
1
Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L Bromodomains.

Bayer
1
Design of a Chemical Probe for the Bromodomain and Plant Homeodomain Finger-Containing (BRPF) Family of Proteins.

University College London
4
Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their use

St George'S Hosptial Medical School
55
Tyrosine kinase inhibitors. 16. 6,5,6-tricyclic benzothieno[3, 2-d]pyrimidines and pyrimido[5,4-b-] and -[4,5-b]indoles as potent inhibitors of the epidermal growth factor receptor tyrosine kinase.

Parke-Davis Pharmaceutical Research